Veracyte, Inc.
- VCYT
- NASDAQ
- Medical - Diagnostics & Research
- Genomic Diagnostics
- Cancer Diagnostics (Thyroid/Prostate/Bladder)
$43.80
Today +1.58%Quote Oct 19, 2026, 08:00 PM UTC
+10.05%over the last month
Max drawdown −11.2%From 1-month high −9.8%3 months −26.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Veracyte
Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
Where the money comes from
Q2 2026 revenue $150.3M
- Testing$145.7M96.9%
- Product$3.9M2.6%
- Biopharmaceutical And Other$802,0000.5%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
755
Founded
2006
Market value
$3.52B
Quote Oct 19
Floor
$43.69
0.3% below price
Resistance
$43.70
Price is above this level
Price vs analyst targets
22 analysts
Lowest target
$44.00Highest target
$69.00
$44.00Highest target
$69.00
- Price $43.80
- Average target $57.43
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 31% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VCYTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free